HotCopper.com on MSN2d
'East to West': AdAlta unveils new strategy to find drug candidates, but appears to've ditched AD-214
AdAlta (ASX:1AD) has unveiled a new grand plan to take cell therapy candidates from Southeast Asia, firm them up in ...
stockhead2d
AdAlta prioritises ‘East to West’ cellular immunotherapy strategy to drive value creation
AdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.
Hosted on MSN5d
AdAlta boosts leadership in Q2 FY25 to support growth strategy
FY25 saw AdAlta focus on increasing its corporate muscle, with two new board members and additional advisors engaged. ...